Compass Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,221
Closed -$257K 88
2025
Q3
$257K Hold
3,221
0.06% 139
2025
Q2
$293K Buy
3,221
+8
+0.2% +$730 0.07% 134
2025
Q1
$301K Hold
3,213
0.08% 130
2024
Q4
$292K Hold
3,213
0.07% 136
2024
Q3
$334K Hold
3,213
0.08% 135
2024
Q2
$312K Hold
3,213
0.08% 134
2024
Q1
$289K Hold
3,213
0.07% 137
2023
Q4
$256K Hold
3,213
0.07% 139
2023
Q3
$228K Hold
3,213
0.07% 148
2023
Q2
$248K Hold
3,213
0.07% 146
2023
Q1
$241K Hold
3,213
0.08% 146
2022
Q4
$253K Buy
+3,213
New +$241K 0.08% 141

Other funds holding CL

Compass Wealth Management's CL Position: Q4 2025 in Review

Compass Wealth Management sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 3,221 shares — an estimated $257K sold.

Compass Wealth Management first reported a position in CL in Q4 2022 and held it in 12 quarters. The position peaked at $334K in Q3 2024. 1,887 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Compass Wealth Management reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Compass Wealth Management sold 3,221 Colgate-Palmolive shares in Q4 2025, an estimated $257K.
  • Compass Wealth Management first reported a position in Colgate-Palmolive in Q4 2022 and held it in 12 quarters.
  • Compass Wealth Management's Colgate-Palmolive position peaked at $334K in Q3 2024.
  • 1,887 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Compass Wealth Management's 13F filing for Q4 2025, filed 11 Feb 2026.